Free Account Opening + AMC Free Demat
Loading...

Eris Lifesciences IPO vs S Chand and Company IPO

Comparision between Eris Lifesciences IPO and S Chand and Company IPO.

IPO Details

Eris Lifesciences IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while S Chand and Company IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Eris Lifesciences IPO is up to ₹1,741.16 Cr whereas the issue size of the S Chand and Company IPO is up to ₹728.56 Cr. The final issue price of Eris Lifesciences IPO is ₹603.00 per share and of S Chand and Company IPO is ₹670.00 per share.

  Eris Lifesciences IPO S Chand and Company IPO
Face Value ₹1 per share ₹5 per share
Issue Price (Lower) ₹600.00 per share ₹660.00 per share
Issue Price (Upper) ₹603.00 per share ₹670.00 per share
Issue Price (Final) ₹603.00 per share ₹670.00 per share
Discount (Retail)
Discount (Employee) ₹60.00 per share
Market Lot Size 24 shares 22 shares
Fresh Issue Size 48,50,746 shares
Fresh Issue Size (Amount) up to ₹325.00 Cr
OFS Issue Size 2,88,75,000 shares 60,23,236 shares
OFS Issue Size (Amount) up to ₹403.56 Cr
Issue Size Total 2,88,75,000 shares 1,08,73,982 shares
Issue Size Total (Amount) up to ₹1,741.16 Cr up to ₹728.56 Cr

IPO Timetable

Eris Lifesciences IPO opens on Jun 16, 2017, while S Chand and Company IPO opens on Apr 26, 2017. The closing date of Eris Lifesciences IPO and S Chand and Company IPO is Jun 20, 2017, and Apr 28, 2017, respectively.

  Eris Lifesciences IPO S Chand and Company IPO
Anchor Bid Date
Issue Open Jun 16, 2017 Apr 26, 2017
Issue Close Jun 20, 2017 Apr 28, 2017
Basis Of Allotment (Tentative) Jun 23, 2017 May 04, 2017
Initiation of Refunds (Tentative) Jun 27, 2017 May 05, 2017
Credit of Share (Tentative) Jun 28, 2017 May 08, 2017
Listing date (Tentative) Jun 29, 2017 May 09, 2017
Anchor Lockin End date 1 Jul 23, 2017 Jun 03, 2017
Anchor Lockin End date 2 Sep 21, 2017 Aug 02, 2017

Financials

Eris Lifesciences IPO P/E ratio is , as compared to S Chand and Company IPO P/E ratio of .

  Eris Lifesciences IPO S Chand and Company IPO
Financial
Summary of financial Information (Consolidated)
Particulars For the year/period ended (in Rs. Million)
31-Mar-16 31-Mar-15 31-Mar-14 31-Mar-13 31-Mar-12
Total Assets 3,973.59 3,572.85 2,705.99 1,718.05 1,019.67
Total Revenue 5,970.21 5,455.58 5,088.22 3,930.64 2,739.40
Profit After Tax 1,348.58 892.59 709.12 584.40 370.63
Summary of financial Information
Particulars For the year/period ended (in Rs. Million)
31-Dec-16 31-Mar-16 31-Mar-15 31-Mar-14 31-Mar-13 31-Mar-12
Total Assets 7,431.94 6,854.89 5,315.98 4,242.82 3,988.05 2,076.88
Total Revenue 922.12 2,822.53 2,357.88 2,300.32 1,921.72 1,713.21
Profit After Tax (PAT) (300.39) 164.80 76.85 108.62 71.65 88.53
Promoter Shareholding (Pre-Issue)
Promoter Shareholding (Post-Issue)
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Eris Lifesciences IPO retail investors (RII) are offered 28,72,500 shares while in S Chand and Company IPO retail investors are offered 28,72,500 shares. Qualified institutional buyers (QIB) are offered 86,17,500 shares in Eris Lifesciences IPO and in S Chand and Company IPO.

  Eris Lifesciences IPO S Chand and Company IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 86,17,500 shares
NII 43,08,750 shares
RII 28,72,500 shares
Employee 1,50,000 shares
Others
Total 1,59,48,750 shares

Bids Received (Subscription)

Eris Lifesciences IPO subscribed 3.29x in total, whereas S Chand and Company IPO subscribed 59.49x.

  Eris Lifesciences IPO S Chand and Company IPO
QIB (times) 4.68x 44.27x
NII (times) 0.45x 204.65x
Big NII (times)
Small NII (times)
RII (times) 3.51x 6.07x
Employee (times) 0.86x
Other (times)
Total (times) 3.29x 59.49x

Comments

Add a public comment...